0.2.0 - ci-build

ONCOnnectTumorboardIG - Local Development build (v0.2.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

: Oncological History Guideline (Example) - XML Representation

Raw xml | Download


<CarePlan xmlns="http://hl7.org/fhir">
  <id value="ONCOnnect-EX-TB-OncologicalHistoryGuideline"/>
  <meta>
    <profile
             value="https://tumorboards-ig.app.ccc-onconnect.de/StructureDefinition/onconnect-pr-tb-oncological-history-guideline"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CarePlan ONCOnnect-EX-TB-OncologicalHistoryGuideline</b></p><a name="ONCOnnect-EX-TB-OncologicalHistoryGuideline"> </a><a name="hcONCOnnect-EX-TB-OncologicalHistoryGuideline"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-onconnect-pr-tb-oncological-history-guideline.html">Oncological History Guideline (Profile)</a></p></div><p><b>status</b>: Completed</p><p><b>intent</b>: Plan</p><p><b>description</b>: Second guideline therapy completed for the patient.</p><p><b>subject</b>: <a href="Patient-ONCOnnect-EX-TB-Patient.html">Leo Muster (official) Other, DoB: 1980-04-06 ( Krankenversichertennummer)</a></p><p><b>period</b>: 2023-06-01 --&gt; 2023-12-01</p><p><b>note</b>: </p><blockquote><div><p>2023-12-01: Completion of the second guideline therapy as per the oncological treatment plan.</p>
</div></blockquote></div>
  </text>
  <status value="completed"/>
  <intent value="plan"/>
  <description value="Second guideline therapy completed for the patient."/>
  <subject>🔗 
    <reference value="Patient/ONCOnnect-EX-TB-Patient"/>
  </subject>
  <period>
    <start value="2023-06-01"/>
    <end value="2023-12-01"/>
  </period>
  <note>
    <text
          value="2023-12-01: Completion of the second guideline therapy as per the oncological treatment plan."/>
  </note>
</CarePlan>